Replies to post #536825 on NorthWest Biotherapeutics Inc (NWBO)

[jfr1611]

What about a JV announcement (19,9% participation investment) + cash for co development of DCVAX-L.
Similar kind of news Merck/Seagen announced last august.
The share acquisition was at ~50% premium.
Go and read it.

[exwannabe]

Next two big milestones for NWBO are combo patent and facility certification. The deal may or may not wait for these two milestones.

Neither are big milestones for NWBO.

For Advent, yeah, the commercial license does matter. But they are just a CDMO that NWBO could use. Just like CRL or others.

The combo patent will not move the needle.

Outside of partner/buyout/approval the only news I could see that would matter is submission of a BLA/MAA.

[Poor Man -]

These are all good points, IMHO.

The science is validated, and that clears a path for everything else. My hope is that Les is spending the day reviewing and marking up all the final transaction documents for the partnership and listing.

One clue: if there is no cascade of PRs coming out from the company starting this week, then it is the silence before the big tornado, big news will drop very soon.

Next two big milestones for NWBO are combo patent and facility certification. The deal may or may not wait for these two milestones.

The most important thing for NWBO is that the science is validated and NWBO is for real, now the huge potential is there and for real, everything else after that is trivial and matter of execution which the BP also can do it and do it better.